Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgery plus Chemotherapy vs Chemotherapy in Distal Gastric Cancer
NCT03399253Phase 3Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Dec 2017
- Primary completion
- Nov 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall Survival at 5 years. Started Dec 2017; status: recruiting.
Beyond the preview
Go deeper on NCT03399253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03399253.